ARCHIVES

Dasatinib, Nilotinib Show Strong Early Results As Frontline Therapy For CML

This article is from The Cancer Letter archive.

Vol. 30 No. 12 | December 28, 2007

Download PDF Visit The Full Archive

Related Articles

Older Patients Can Do Well With Stem Cell Transplants

March 30, 2007

Model Projects 54,900 New Lung Cancer Cases In 5 Years with Nationwide LDCT Screening

May 30, 2014

New Drug Reverses Damage To Liver In Stem Cell Transplant

September 27, 2002

In Brief: Thomas Jefferson Univ. Wins $5 Mil. P01; Former NCI Administrator Sentenced

November 6, 1992

In Brief: Gigliotti Named Greenwald Special Assistant; Coltman To Get ACCC Clinical Research Award

August 26, 1988

Continous Hormone Therapy Superior To Intermittent In 17-Year SWOG Study

June 29, 2012